Parthasarathy, Shobita (Author)
This dissertation compares the development of genetic testing for breast cancer in the United States and Britain. In the mid-1990s, scientists discovered BRCA1 and BRCA2, two genes linked to inherited predisposition for breast and ovarian cancer. Soon after these discoveries, organizations across the world began to develop diagnostic testing services based on the new information. Meanwhile, patient advocates, scientific and professional organizations, bioethicists, government advisory committees, and the media tried to influence the development of this new genetic technology. These groups viewed BRCA testing as a test case, one that would provide an early glimpse of the future of genetic medicine---in terms of who would provide these technologies, how they would be regulated, and how newly generated genetic information might be used. Based on qualitative research that included interviews, document collection, and participant observation, the dissertation explores how BRCA testing services were built in the US and Britain, the implications of these services for the participants involved, and how the services were integrated into health care in the two countries. It demonstrates how these technologies were constructed differently in different national contexts, and argues that each technology prescribed a particular moral order---specific rights, roles, responsibilities, and authority---for the participants who came into contact with it, such as health care professionals and individuals interested in testing. The specific shapes of BRCA testing in each country also influenced how individuals at- risk for breast and/or ovarian cancer were identified and treated. Despite these differences in the shapes and consequences of their technologies, however, American and British providers integrated the new technology into their respective health care systems in a similar manner; each argued that BRCA testing would be particularly empowering for its users. The dissertation concludes by investigating the response of British health care professionals, scientists, and advocacy groups to Myriad's attempt to expand its BRCA testing technology to Britain. These groups resisted the technology transfer, arguing that Myriad's uniquely American testing service had no place in the British health care system. Despite a world that seems increasingly global, with numerous transnational linkages, national context it seems, still does matter.
...MoreDescription Cited in Diss. Abstr. Int. A 64 (2003): 666. UMI order no. 3081360.
Book
Parthasarathy, Shobita;
(2007)
Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care
(/isis/citation/CBB000953852/)
Article
Parthasarathy, Shobita;
(2005)
Architectures of Genetic Medicine: Comparing Genetic Testing for Breast Cancer in the USA and the UK
(/isis/citation/CBB000650978/)
Article
Zavestoski, Stephen;
McCormick, Sabrina;
Brown, Phil;
(2004)
Gender, Embodiment, and Disease: Environmental Breast Cancer Activists' Challenges to Science, the Biomedical Model, and Policy
(/isis/citation/CBB000640434/)
Book
Aronowitz, Robert A.;
(2007)
Unnatural History: Breast Cancer and American Society
(/isis/citation/CBB000900080/)
Article
Esther Diana;
(2021)
Not only a female icon: The breast in symbolism and medicine (from the 14th to the 17th centuries)
(/isis/citation/CBB711184543/)
Article
Wu, Yi-Li;
(2011)
Body, Gender, and Disease: The Female Breast in Late Imperial Chinese Medicine
(/isis/citation/CBB001231844/)
Article
Alessandro Rosa;
(2021)
Rethinking health and disease in the era of personalized medicine
(/isis/citation/CBB416070087/)
Book
Olson, James S.;
(2002)
Bathsheba's Breast: Women, Cancer, and History
(/isis/citation/CBB000201506/)
Thesis
Myhre, Jennifer Reid;
(2001)
Medical Mavens: Gender, Science, and the Consensus Politics of Breast Cancer Activism
(/isis/citation/CBB001562391/)
Article
Mark, Harry M.;
(2006)
“Until the Sun of Science...the True Apollo of Medicine Has Risen”: Collective Investigation in Britain and America, 1880--1910
(/isis/citation/CBB000773952/)
Article
Knaapen, Loes;
Weisz, George;
(2008)
The Biomedical Standardization of Premenstrual Syndrome
(/isis/citation/CBB000830442/)
Article
Pearce, J. M. S.;
(2013)
John Fothergill: A Biographical Sketch and his Contributions to Neurology
(/isis/citation/CBB001320366/)
Article
Cantor, David;
(2007)
Introduction: Cancer Control and Prevention in the Twentieth Century
(/isis/citation/CBB000700694/)
Article
Teixeira, Luiz Antonio;
(2010)
O controle do câncer no Brasil na primeira metade do século XX
(/isis/citation/CBB001420480/)
Book
English, Peter C.;
(1999)
Rheumatic fever in America and Britain: A biological, epidemiological, and medical history
(/isis/citation/CBB000111147/)
Article
Jasen, Patricia;
(2005)
Breast Cancer and the Politics of Abortion in the United States
(/isis/citation/CBB000773943/)
Article
Dale, Pamela;
Greenlees, Janet;
Melling, Joseph;
(2007)
The Kiss of Death or a Flight of Fancy? Workers' Health and the Campaign to Regulate Shuttle Kissing in the British Cotton Industry, c. 1900--52
(/isis/citation/CBB001030541/)
Article
Shirley Sun;
Ann Hui Ching;
(2021)
Social Systems Matter: Precision Medicine, Public Health, and the Medical Model
(/isis/citation/CBB879164513/)
Article
Leeming, William;
(2011)
Graphical and Computationally Intensive Techniques for Presenting and Disseminating Information about the Genetics of Disease: Possibilities, Limitations, and Additions
(/isis/citation/CBB001320110/)
Thesis
Finn, Lisa;
(2004)
Risky Subjects: Constructions and Categorizations of Women in Health Care
(/isis/citation/CBB001561923/)
Be the first to comment!